TH-302
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for TH-302, covering 2014-04-21 to 2020-07-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours [Phase 2]